BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

539206

GVBL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

GENOMIC VALLEY BIOTECH LIMITED Share Price Update

As of the latest trading session, GENOMIC VALLEY BIOTECH LIMITED share price is currently at ₹ 31.83, which is down by ₹ -0.02 from its previous closing. Today, the stock has fluctuated between ₹ 30.02 and ₹ 31.89. Over the past year, GENOMIC VALLEY BIOTECH LIMITED has achieved a return of -63.45 %. In the last month alone, the return has been -18.67 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

GENOMIC VALLEY BIOTECH LIMITED fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    9.70

  • P/E Ratio (TTM)

    39.79

  • Beta

    0.34

  • Book Value / share

    12.75

  • Return on equity

    0.57%

  • EPS (TTM)

    0.80

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.02

info icon alternate text

GENOMIC VALLEY BIOTECH LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 0.09
Operating Expense 0.07
Net Profit 0.02
Net Profit Margin (%) 22.22
Earnings Per Share (EPS) 0.08
EBITDA 0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.26
Operating Expense 0.26
Net Profit -0.08
Net Profit Margin (%) -30.76
Earnings Per Share (EPS) -0.27
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.22
Operating Expense 0.07
Net Profit 0.16
Net Profit Margin (%) 72.72
Earnings Per Share (EPS) 0.51
EBITDA 0.16
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.21
Operating Expense 0.06
Net Profit 0.15
Net Profit Margin (%) 71.42
Earnings Per Share (EPS) 0.48
EBITDA 0.15
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.16
Operating Expense 0.03
Net Profit 0.13
Net Profit Margin (%) 81.25
Earnings Per Share (EPS) 0.42
EBITDA 0.13
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.84
Operating Expense 0.41
Net Profit 0.36
Net Profit Margin (%) 42.85
Earnings Per Share (EPS) 1.17
EBITDA 0.44
Effective Tax Rate (%) 20.45
Particulars MAR 2024 (Values in Cr)
Revenue 0.17
Operating Expense 0.15
Net Profit 0.02
Net Profit Margin (%) 11.76
Earnings Per Share (EPS) 0.05
EBITDA 0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 2.72
Operating Expense 1.85
Net Profit 0.65
Net Profit Margin (%) 23.89
Earnings Per Share (EPS) 2.12
EBITDA 0.66
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.07
Operating Expense 0.57
Net Profit -0.01
Net Profit Margin (%) -14.28
Earnings Per Share (EPS) -0.03
EBITDA 0.12
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.21
Operating Expense 0.72
Net Profit -0.56
Net Profit Margin (%) -266.66
Earnings Per Share (EPS) -1.83
EBITDA -0.13
Effective Tax Rate (%) -12.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.60
ROE % 0.57
ROCE % 0.57
Total Debt to Total Equity 0.00
EBITDA Margin 11.76
Particulars MAR 2023 (Values in Cr)
Book Value / Share 11.55
ROE % 28.48
ROCE % 25.67
Total Debt to Total Equity 0.00
EBITDA Margin 33.82
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.42
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.21
EBITDA Margin -428.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 14.69
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.32
EBITDA Margin -61.90
Particulars MAR 2020 (Values in Cr)
Book Value / Share 16.52
ROE % 5.84
ROCE % 5.39
Total Debt to Total Equity 0.30
EBITDA Margin 65.88
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 4.33
Total Liabilities 4.33
Total Equity 3.54
Share Outstanding 3054500
Price to Book Ratio 2.99
Return on Assets (%) 0.35
Return on Capital (%) 0.43
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 4.42
Total Liabilities 4.42
Total Equity 3.52
Share Outstanding 3054500
Price to Book Ratio 0.00
Return on Assets (%) 14.66
Return on Capital (%) 18.38
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 3.79
Total Liabilities 3.79
Total Equity 2.87
Share Outstanding 3054500
Price to Book Ratio 0.00
Return on Assets (%) -0.24
Return on Capital (%) -0.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 7.61
Total Liabilities 7.61
Total Equity 4.48
Share Outstanding 3054500
Price to Book Ratio 0.00
Return on Assets (%) -7.33
Return on Capital (%) -9.26
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 8.00
Total Liabilities 8.00
Total Equity 5.04
Share Outstanding 3054500
Price to Book Ratio 0.00
Return on Assets (%) 3.57
Return on Capital (%) 4.38
Particulars MAR 2024 (Values in Cr)
Net Income 0.01
Cash from Operations -0.02
Cash from Investing -0.01
Cash from Financing 0.00
Net change in Cash -0.03
Free Cash Flow -0.02
Particulars MAR 2023 (Values in Cr)
Net Income 0.91
Cash from Operations -0.77
Cash from Investing 1.52
Cash from Financing -0.70
Net change in Cash 0.03
Free Cash Flow -0.77
Particulars MAR 2022 (Values in Cr)
Net Income -0.42
Cash from Operations -2.12
Cash from Investing 3.66
Cash from Financing -1.54
Net change in Cash 0.00
Free Cash Flow -2.12
Particulars MAR 2021 (Values in Cr)
Net Income -0.50
Cash from Operations 1.48
Cash from Investing -1.57
Cash from Financing 0.06
Net change in Cash -0.02
Free Cash Flow 3.06
Particulars MAR 2020 (Values in Cr)
Net Income 0.20
Cash from Operations 0.43
Cash from Investing -0.47
Cash from Financing 0.00
Net change in Cash -0.03
Free Cash Flow 0.91
Company Name Price P/E P/B Market Cap 52 Week Low/High
KESORAM INDUSTRIES LTD 5.20 0.00 0.35 161.57 2.94 / 11.79
MAX FINANCIAL SERV LTD 1583.10 200.65 10.35 54635.12 972.55 / 1678.80
MODI RUBBER LTD 130.55 17.59 0.60 326.90 87.25 / 163.90
THOMAS COOK (INDIA) LTD 152.80 28.14 4.23 7195.25 118.10 / 225.45
RAIN INDUSTRIES LIMITED 130.90 0.00 0.62 4402.82 117.30 / 196.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
FGP LTD. 9.15 0.00 3.25 10.88 7.32 / 13.70
KESORAM INDUSTRIES LTD 5.20 0.00 0.29 161.57 2.94 / 11.79
MPIL CORPORATION LTD. 576.50 0.00 2.61 32.86 446.60 / 787.35
MAX FINANCIAL SERV LTD 1583.10 0.00 8.10 54635.12 972.55 / 1678.80

GENOMIC VALLEY BIOTECH LIMITED shareholding pattern

Holding

Others
53.28%
Promoter Holdings
46.71%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Yogesh Agrawal 1427000.0 (46.72%) Shareholding of Promoter and Promoter Group
Deepti Aggarwal 336000.0 (11.0%) Public Shareholding
Amar Aggarwal 276510.0 (9.05%) Public Shareholding
Vikram Ashokkumar Jain 168100.0 (5.5%) Public Shareholding
Purushothaman Shaji 80560.0 (2.64%) Public Shareholding
Parul Agrawal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ojaswini Avantika 0.0 (0.0%) Shareholding of Promoter and Promoter Group

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

GENOMIC VALLEY BIOTECH LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
31.83 -0.06 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 32.10
  • 26 Days 35.90
  • 10 Days 33.00
  • 50 Days 39.20
  • 12 Days 33.40
  • 100 Days 44.50
  • 20 Days 34.90
  • 200 Days 50.60
31.56 PIVOT

First Support

31.19

First Resistance

32.22

Second Support

30.53

Second Resistance

32.59

Third Support

30.16

Third Resistance

33.25

RSI

28.21

ADX

61.07

MACD

-2.51

Williams % R

-79.04

Commodity Channel Index (CCI)

-106.03

Date

2025-10-10

Week

2079.00

Same Day

1208.00

Month

3341.00

1 Year

0.34

3 Year

0.37

Over 1 Month

-18.67%

down

Over 1 Year

-63.45%

down

Over 3 Months

-36.97%

down

Over 3 Years

-0.64%

down

Over 6 Months

-47.21%

down

Over 5 Years

11.34%

down

GENOMIC VALLEY BIOTECH LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

GENOMIC VALLEY BIOTECH LIMITED Share Price

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally. The Company is extensively involved in commercial greenhouse / poly house cultivation of crops. Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer. Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

The Company identified a cluster of 300 marginal farmers eligible to form a Farmers Producer Company. It already started opening a training centre, imparting training to farmers and agri-entrepreneurs profitably. Separate courses have been designed for Training like the Ladies to develop kitchen gardens or small farms which can fetch them profits by growing fruits and vegetables. Apart from this, the Company is also providing Agri Farming Consultancy to farmers and other clients on case to case basis.

The Company is taking up turnkey cultivation projects of its clients on clients land with assured buy back and marketing assurance. And finally when production of vegetables comes, the Company shoulders all responsibilities to sell produce in the market to pay the assured amount to client. The Company is having a commercial plant tissue culture laboratory and has the production capacity of 3 million plants per annum.

The Company is in process to do all the documentations for getting started with the operation of the Producer Company.

Parent organization Indian Private
NSE symbol [-]
Founded 1994
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Genomic Valley Biotech Ltd?

Answer Field

Genomic Valley Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 31.83 as on Oct 10 2025 03:29 PM.

What is the Market Cap of Genomic Valley Biotech Ltd Share?

Answer Field

The market cap of Genomic Valley Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 9.70 as on Oct 10 2025 03:29 PM.

What is the 52 Week High and Low of Genomic Valley Biotech Ltd?

Answer Field

The 52 Week High and Low of Genomic Valley Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 108.15 and ₹ 30.00.

What is 1 year return for Genomic Valley Biotech Ltd?

Answer Field

The 1 year returns on the stock has been -63.45%.

What is the P/E Ratio of Genomic Valley Biotech Ltd Share?

Answer Field

As on Oct 10 2025 03:29 PM the price-to-earnings (PE) ratio for Genomic Valley Biotech Ltd share is 39.79.

What is the PB ratio of Genomic Valley Biotech Ltd Share?

Answer Field

As on Oct 10 2025 03:29 PM, the price-to-book (PB) ratio for Genomic Valley Biotech Ltd share is 12.75.

How to Buy Genomic Valley Biotech Ltd Share?

Answer Field

You can trade in Genomic Valley Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Genomic Valley Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Genomic Valley Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Genomic Valley Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59